Citigroup’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.9K Sell
48,544
-48,424
-50% -$45.8K ﹤0.01% 4076
2025
Q1
$44.7K Sell
96,968
-9,818
-9% -$4.52K ﹤0.01% 4136
2024
Q4
$78.9K Buy
106,786
+17,041
+19% +$12.6K ﹤0.01% 4094
2024
Q3
$141K Buy
89,745
+56,615
+171% +$88.9K ﹤0.01% 3820
2024
Q2
$55.7K Buy
33,130
+15,582
+89% +$26.2K ﹤0.01% 3788
2024
Q1
$42.1K Sell
17,548
-207,450
-92% -$498K ﹤0.01% 3964
2023
Q4
$344K Buy
224,998
+188,983
+525% +$289K ﹤0.01% 2918
2023
Q3
$39.3K Buy
36,015
+2,528
+8% +$2.76K ﹤0.01% 3524
2023
Q2
$76.7K Buy
33,487
+29,442
+728% +$67.4K ﹤0.01% 3698
2023
Q1
$9.83K Sell
4,045
-172
-4% -$418 ﹤0.01% 4078
2022
Q4
$8.05K Sell
4,217
-420
-9% -$802 ﹤0.01% 4199
2022
Q3
$11K Sell
4,637
-11,916
-72% -$28.3K ﹤0.01% 4219
2022
Q2
$31K Buy
16,553
+7,877
+91% +$14.8K ﹤0.01% 4090
2022
Q1
$18K Sell
8,676
-14,931
-63% -$31K ﹤0.01% 4465
2021
Q4
$93K Buy
23,607
+14,672
+164% +$57.8K ﹤0.01% 4007
2021
Q3
$43K Sell
8,935
-2,660
-23% -$12.8K ﹤0.01% 4070
2021
Q2
$53K Buy
11,595
+8,124
+234% +$37.1K ﹤0.01% 4123
2021
Q1
$20K Sell
3,471
-88,416
-96% -$509K ﹤0.01% 4591
2020
Q4
$314K Sell
91,887
-12,296
-12% -$42K ﹤0.01% 2948
2020
Q3
$150K Buy
104,183
+91,950
+752% +$132K ﹤0.01% 2925
2020
Q2
$24K Sell
12,233
-6,370
-34% -$12.5K ﹤0.01% 4138
2020
Q1
$36K Buy
18,603
+715
+4% +$1.38K ﹤0.01% 4031
2019
Q4
$74K Sell
17,888
-30,505
-63% -$126K ﹤0.01% 3718
2019
Q3
$146K Sell
48,393
-93,931
-66% -$283K ﹤0.01% 3256
2019
Q2
$895K Buy
142,324
+29,885
+27% +$188K ﹤0.01% 2224
2019
Q1
$626K Sell
112,439
-285,205
-72% -$1.59M ﹤0.01% 2326
2018
Q4
$2.64M Buy
397,644
+129,687
+48% +$861K ﹤0.01% 1360
2018
Q3
$2.86M Buy
267,957
+99,771
+59% +$1.06M ﹤0.01% 1293
2018
Q2
$2.02M Buy
168,186
+108,333
+181% +$1.3M ﹤0.01% 1472
2018
Q1
$513K Sell
59,853
-18,105
-23% -$155K ﹤0.01% 2290
2017
Q4
$770K Buy
77,958
+4,866
+7% +$48.1K ﹤0.01% 2052
2017
Q3
$899K Buy
73,092
+29,162
+66% +$359K ﹤0.01% 2011
2017
Q2
$723K Buy
43,930
+1,819
+4% +$29.9K ﹤0.01% 2191
2017
Q1
$604K Sell
42,111
-108,989
-72% -$1.56M ﹤0.01% 2290
2016
Q4
$2.09M Buy
151,100
+124,391
+466% +$1.72M ﹤0.01% 1810
2016
Q3
$483K Buy
26,709
+13,044
+95% +$236K ﹤0.01% 2451
2016
Q2
$196K Sell
13,665
-28,861
-68% -$414K ﹤0.01% 2883
2016
Q1
$508K Buy
42,526
+36,492
+605% +$436K ﹤0.01% 2669
2015
Q4
$80K Sell
6,034
-45,219
-88% -$600K ﹤0.01% 3738
2015
Q3
$550K Buy
51,253
+36,460
+246% +$391K ﹤0.01% 2146
2015
Q2
$119K Sell
14,793
-1,304
-8% -$10.5K ﹤0.01% 3131
2015
Q1
$106K Sell
16,097
-5,787
-26% -$38.1K ﹤0.01% 3367
2014
Q4
$139K Buy
21,884
+17,876
+446% +$114K ﹤0.01% 3418
2014
Q3
$40K Sell
4,008
-283
-7% -$2.82K ﹤0.01% 3819
2014
Q2
$48K Sell
4,291
-12,056
-74% -$135K ﹤0.01% 3583
2014
Q1
$198K Buy
16,347
+361
+2% +$4.37K ﹤0.01% 2873
2013
Q4
$202K Buy
15,986
+1,331
+9% +$16.8K ﹤0.01% 3139
2013
Q3
$244K Buy
14,655
+12,050
+463% +$201K ﹤0.01% 2449
2013
Q2
$40K Buy
+2,605
New +$40K ﹤0.01% 3884